Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma

被引:1
|
作者
Becherini, Carlotta [1 ]
Banini, Marco [2 ,3 ]
Desideri, Isacco [2 ]
Salvestrini, Viola [2 ]
Caprara, Luisa [2 ]
Scotti, Vieri [1 ]
Ganovelli, Michele [2 ]
Morelli, Ilaria [2 ]
Romei, Andrea [2 ]
Livi, Lorenzo [1 ,2 ]
Bonomo, Pierluigi [1 ]
机构
[1] Azienda Osped Univ Careggi, Radiat Oncol Dept, Florence, Italy
[2] Univ Florence, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy
[3] Univ Florence, Radiat Oncol Dept, AOU Careggi, Lgo Brambilla 3, I-50134 Florence, Italy
关键词
Nivolumab; Older patients; Immunotherapy; Geriatric oncology; Head and neck cancer; CANCER; CHEMOTHERAPY; MANAGEMENT; CETUXIMAB; RECURRENT;
D O I
10.1016/j.jgo.2022.09.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Outcome of chemotherapy following nivolumab treatment for recurrent and/or metastatic head and neck squamous cell carcinoma
    Wakasaki, Takahiro
    Yasumatsu, Ryuji
    Uchi, Ryutaro
    Taura, Masahiko
    Matsuo, Mioko
    Komune, Noritaka
    Nakagawa, Takashi
    [J]. AURIS NASUS LARYNX, 2020, 47 (01) : 116 - 122
  • [2] Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma
    Zargar, Mahdi
    McFarlane, Thomas
    Chan, Kelvin K. W.
    Wong, William W. L.
    [J]. ONCOLOGIST, 2018, 23 (02): : 225 - 233
  • [3] Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Papaxoinis, George
    Gavrielatou, Niki
    Anastasiou, Maria
    Pantazopoulos, Anastasios
    Kavourakis, George
    Gkolfinopoulos, Stavros
    Panayiotides, Ioannis
    Delides, Alexandros
    Psyrri, Amanda
    [J]. ORAL ONCOLOGY, 2020, 111
  • [4] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1856 - 1867
  • [6] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [7] Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Guiard, Emeline
    Clatot, Florian
    Even, Caroline
    Perreard, Marion
    Abdeddaim, Cyril
    Johnson, Alison
    Vauleon, Elodie
    Rambeau, Audrey
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 159 : 125 - 132
  • [8] Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
    Okada, Takuro
    Matsuki, Takashi
    Fushimi, Chihiro
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Tokashiki, Kunihiko
    Ito, Tatsuya
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Kouki
    Hanyu, Kenji
    Omura, Go
    Takahashi, Hideki
    Yamashita, Taku
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    [J]. ANTICANCER RESEARCH, 2022, 42 (10) : 4907 - 4912
  • [9] Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck: A Tertiary Cancer Center Experience
    Pareek, Ananya
    Patel, Apurva A.
    Kumar, Mukesh
    Kuttikat, Philip G.
    Annadanam, Harshavardhan
    Pendse, Shantanu
    Mohammed, Naseer
    Panchal, Harsha P.
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2022, 11 (01) : 58 - 61
  • [10] Clinical outcomes in patients with recurrent or metastatic head and neck squamous cell carcinoma after failure of platinum and nivolumab: A multicenter retrospective study
    Oka, H.
    Nagashima, K.
    Nishi, H.
    Kumai, Y.
    Iijima, H.
    Okami, K.
    Shimizu, Y.
    Kano, S.
    Ito, K.
    Yamazaki, T.
    Takahashi, H.
    Oridate, N.
    Yokota, T.
    Koyama, T.
    Kiyota, N.
    Kato, K.
    Kadowaki, S.
    Honma, Y.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S853 - S854